Skip to main content

Matthew B. Harms, MD, an associate professor of neurology at Columbia University, gave clinical insights on the advances in ALS genetic research and what clinicians can expect from the ALS/FTD track at the 2025 MDA Clinical & Scientific Conference.:

Source: Neurology Read More